Biologic treatments in Behçet’s disease

QR Code

Biologic treatments in Behçet’s disease

Saved in:

Bibliographic Details
Main Authors:	Fatma Alibaz-Öner, Haner Direskeneli
Format:	article
Language:	EN
Published:	AVES Yayincilik 2021
Subjects:	Immunologic diseases. Allergy RC581-607
Online Access:	https://doaj.org/article/49bb77033fad4823911fc509aef22d4e
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
by: Yusuf Karabulut
Published: (2021)

Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients
by: Cemal Gürbüz, et al.
Published: (2021)

Acute necrotizing pancreatitis as a manifestation of Behcet’s Disease: A case report and review of the literature
by: Geilan A. Mahmoud, et al.
Published: (2022)

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases
by: Cosimo Bruni, et al.
Published: (2021)

Features of systemic cytokine production in Behcet's disease associated with uveitis without ocular lesions
by: E. S. Sorozhkina, et al.
Published: (2021)

In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls
by: Helene Broch Tenstad, et al.
Published: (2021)

Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe
by: Zhou DT, et al.
Published: (2015)

EFFECT OF HUMAN HERPES VIRUS REACTIVATION ON SYSTEMIC CYTOKINE PRODUCTION IN PATIENTS WITH BEHCET’S DISEASE AND UVEITIS
by: G. I. Krichevskaya, et al.
Published: (2021)

Ginger extract suppresses the activations of NF-κB and Wnt pathways and protects inflammatory arthritis
by: Burak Öz, et al.
Published: (2021)

Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc
by: Eva Poveda, et al.
Published: (2010)

IMMUNOLOGY OF EYE DISEASES
by: Article Editorial
Published: (2015)

The use of preexposure treatments for HIV prophylaxis
by: Majid A, et al.
Published: (2012)

IMMUNOLOGY OF URINARY SYSTEM DISEASES
by: Article ed
Published: (2015)

IMMUNOLOGY OF CARDIOVASCULAR SYSTEM DISEASES
by: Article Editorial
Published: (2015)

Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
by: Alana MacDonald, et al.
Published: (2021)

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
by: Pandey KK
Published: (2014)

Profile of darunavir in the management of treatment-experienced HIV patients
by: Cameron Wolfe, et al.
Published: (2009)

Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis
by: Sicong Li, et al.
Published: (2021)

Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS
by: Patel TS, et al.
Published: (2013)

The role of etravirine in the management of treatment-experienced pediatric patients with HIV
by: Osterholzer D
Published: (2013)

Long-term treatment of patients with HIV-1: the role of atazanavir
by: Miguel &Aacute;ngel Artacho, et al.
Published: (2010)

Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children
by: Beatriz Larru Martinez, et al.
Published: (2010)

An update on the use of Atripla&reg; in the treatment of HIV in the United States
by: Michael A Horberg, et al.
Published: (2010)

Effect of once-daily FDC treatment era on initiation of cART
by: David M Mosen, et al.
Published: (2010)

Physiotherapy intervention as a complementary treatment for people living with HIV/AIDS
by: Pullen SD, et al.
Published: (2014)

Sexual behaviors and associated factors among antiretroviral treatment attendees in Ethiopia
by: Demissie K, et al.
Published: (2015)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
by: Article Editorial
Published: (2015)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
by: Editorial article
Published: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
by: Editorial article
Published: (2014)

Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
by: Luiz Felipe Domingues Passero, et al.
Published: (2021)

Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
by: Seddon J, et al.
Published: (2011)

Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
by: Thore Lorenzen
Published: (2010)